Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study

T. Harrison (Nottingham, United Kingdom), G. Canonica (Milan, Italy), K. Gemzoe (Uxbridge, United Kingdom), A. Maxwell (Stevenage, United Kingdom), S. Yang (Collegeville, United States of America), S. Joksaite (Uxbridge , United Kingdom), R. O’Reilly (Stevenage, United Kingdom), M. Van Dyke (Upper Providence, United States of America), F. Albers (Research Triangle Park, United States of America), N. Kwon (Brentford, United States of America)

Source: International Congress 2019 – New towards old therapies in airway diseases
Session: New towards old therapies in airway diseases
Session type: Oral Presentation
Number: 2104

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Harrison (Nottingham, United Kingdom), G. Canonica (Milan, Italy), K. Gemzoe (Uxbridge, United Kingdom), A. Maxwell (Stevenage, United Kingdom), S. Yang (Collegeville, United States of America), S. Joksaite (Uxbridge , United Kingdom), R. O’Reilly (Stevenage, United Kingdom), M. Van Dyke (Upper Providence, United States of America), F. Albers (Research Triangle Park, United States of America), N. Kwon (Brentford, United States of America). Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study. 2104

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: